Fengping Xu
BGI Group (China)(CN)Xiamen Tungsten (China)(CN)University of Chinese Academy of Sciences(CN)BGI Research(CN)
Publications by Year
Research Areas
CRISPR and Genetic Engineering, Animal Genetics and Reproduction, Cholangiocarcinoma and Gallbladder Cancer Studies, Epigenetics and DNA Methylation, Pluripotent Stem Cells Research
Most-Cited Works
- → Single‐cell RNA sequencing technologies and applications: A brief overview(2022)1,181 cited
- → Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism(2013)315 cited
- → A Brief Overview of Global Trends in MSC-Based Cell Therapy(2022)277 cited
- → Chromatin accessibility and guide sequence secondary structure affect CRISPR‐Cas9 gene editing efficiency(2017)226 cited
- → Deep sequencing of the MHC region in the Chinese population contributes to studies of complex disease(2016)224 cited
- → A large-scale screen for coding variants predisposing to psoriasis(2013)216 cited